Impact of tumour location and surgical approach on recurrence-free and cancer-specific survival analysis in patients with ureteric tumours

BJU International
Xu BinLouis R Kavoussi

Abstract

What's known on the subject? and What does the study add? Pathological stage, lymph node metastasis and tumour grade have been established as prognostic factors for upper-tract urothelial carcinoma, but there are few studies to date assessing location within the ureter as a prognostic factor. There are also few studies comparing surgical approaches to radical nephroureterectomy (NU), partial ureterectomy and endoscopic resection (ENDO) with regard to oncological outcomes. This study did not find any prognostic significance for tumour location or surgical approach with regard to outcomes in patients with ureteric tumours. Although NU is the standard treatment for invasive ureteric tumours, partial ureterectomy and ENDO can safely be performed in selected patients. Despite the risk of a shorter time to recurrence, ENDO can be recommended in low grade, non-invasive ureteric tumours but only with close, thorough surveillance practices. • To assess the impact of tumour location within the ureter and the impact of surgical approach on recurrence-free survival (RFS) and cancer-specific survival (CSS) with regard to ureteric tumours. • Data were retrospectively reviewed from 60 patients with isolated primary ureteric tumours, treated a...Continue Reading

References

Oct 3, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M OzsahinR O Mirimanoff
Oct 12, 2000·The Journal of Urology·J J Munoz, L M Ellison
Jul 18, 2002·European Urology·Emmanuel DeligneXavier Martin
Nov 7, 2003·The Journal of Urology·Ralph V Clayman
Jul 13, 2004·European Urology·W OosterlinckUNKNOWN European Association of Urology
Aug 24, 2005·European Urology·H G van der PoelS Horenblas
Jul 17, 2007·The Journal of Urology·Amy E KrambeckMichael L Blute
Jan 22, 2008·European Urology·Richard Zigeuner, Karl Pummer
Dec 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eiji KikuchiShahrokh F Shariat
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jul 21, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Giovanni LughezzaniPierre I Karakiewicz
Jul 14, 2010·The Journal of Urology·Vitaly MargulisUNKNOWN Upper Tract Urothelial Carcinoma Collaborative Group

❮ Previous
Next ❯

Citations

Jan 25, 2013·Current Urology Reports·Paul SmithJay D Raman
Sep 17, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·P PuechP Colin
Aug 27, 2014·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·A OuzzaneP Colin
Aug 12, 2014·Urology·Takeshi HashimotoMasaaki Tachibana
Oct 22, 2016·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·D FangL Zhou
Apr 26, 2018·Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research·Zixiong HuangTao Xu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.